Viewing StudyNCT06501664



Ignite Creation Date: 2024-07-17 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06501664
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-15
First Post: 2024-07-09

Brief Title: Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
Sponsor: Rui-hua Xu MD PhD
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Esophageal Cancer
Keywords:
Name View
liposomal irinotecan View
second-line therapy View
esophageal squamous cell carcinoma View